PXED vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

PXED

49.0
AI Score
VS
PXED Wins

UTI

46.2
AI Score

Investment Advisor Scores

PXED

49score
Recommendation
HOLD

UTI

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PXED UTI Winner
Forward P/E 5.5866 27.248 PXED
PEG Ratio 0 1.8142 Tie
Revenue Growth 0.0% 7.2% UTI
Earnings Growth -28.9% -78.9% PXED
Tradestie Score 49.0/100 46.2/100 PXED
Profit Margin 8.2% 3.9% PXED
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PXED 1M: -16.0% · 3M: -27.3% UTI 1M: -6.3% · 3M: -60.7%

Current Technical Phase

PXED

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.8%), weak momentum, RSI 28

RSI (14): 27.8 · Price: $25.19

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.9%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $19.60

Fundamentals Snapshot

Metric PXED UTI
Market Cap — —
Forward P/E 5.5 25.9
Trailing P/E 11.6 30.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.2% 0.0%
EPS 2.19 0.61
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, PXED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.